Xtrackers MSCI Global SDG 3 Good Health UCITS ETF Fund (SWX:XDG3)
Switzerland · Delayed Price · Currency is CHF 27.25
+0.01 (0.04%)
At close: Jul 14, 2025, 5:20 PM CET
-13.88% (1Y)
| Assets | 28.11M |
| Expense Ratio | 0.35% |
| PE Ratio | 20.01 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -13.88% |
| Volume | n/a |
| Open | 27.25 |
| Previous Close | 27.24 |
| Day's Range | 27.25 - 27.25 |
| 52-Week Low | 25.51 |
| 52-Week High | 32.28 |
| Beta | n/a |
| Holdings | 111 |
| Inception Date | Jan 18, 2023 |
About XDG3
XDG3.IR was created on 2023-01-18 by Xtrackers. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 27.62m in AUM and 111 holdings. The fund is passively managed Trackes the The MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index.
Asset Class Equity
Category Health Care
Stock Exchange SIX Swiss Exchange
Ticker Symbol XDG3
Provider Xtrackers
Index Tracked MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index - Benchmark TR Net
Performance
XDG3 had a total return of -13.88% in the past year, including dividends. Since the fund's inception, the average annual return has been -4.40%.
Top 10 Holdings
45.12% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 4.66% |
| Novartis AG | NOVN | 4.64% |
| Gilead Sciences, Inc. | GILD | 4.54% |
| Stryker Corporation | SYK | 4.54% |
| Abbott Laboratories | ABT | 4.49% |
| AbbVie Inc. | ABBV | 4.48% |
| Novo Nordisk A/S | NOVO.B | 4.48% |
| Danaher Corporation | DHR | 4.46% |
| Merck & Co., Inc. | MRK | 4.43% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.39% |